Some genetic loci that regulate blood metabolite concentrations were also associated with CAD risk (NAT2, ABO, CPS1, NAT8, ALPL, KLKB1). The biochemical function of the associated metabolic traits identified may support a possible role in heart disease. This evidence concerns the gene ABO and coronary artery disorder.